help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, S.
Right arrow Articles by Terakawa, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, S.
Right arrow Articles by Terakawa, N.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 2 823-832
Copyright © 2004 by The Endocrine Society

Hepatocyte Growth Factor/Met System Promotes Endometrial and Endometriotic Stromal Cell Invasion via Autocrine and Paracrine Pathways

Souichi Yoshida, Tasuku Harada, Masahiro Mitsunari, Tomio Iwabe, Yasuko Sakamoto, Satoru Tsukihara, Yumiko Iba, Sayako Horie and Naoki Terakawa

Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago 683-8504, Japan

Address all correspondence and requests for reprints to: Souichi Yoshida, M.D. Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago 683-8504, Japan. E-mail: souichi{at}grape.med.tottori-u.ac.jp.

Endometrial stromal cells reportedly have a role in the initial invasion of endometrial tissue into the peritoneum. Hepatocyte growth factor (HGF), which is a ligand for the c-met protooncogene product (Met), stimulates proliferation and invasion of a large number of cells. In this study we investigated the role of the HGF/Met system in the pathogenesis of endometriosis. HGF concentrations in the peritoneal fluid of patients with endometriosis were significantly higher than in those without endometriosis and correlated positively with revised American Society of Reproductive Medicine scores. We showed that the peritoneum and endometriotic stromal cells may be major sources of HGF in peritoneal fluid. Endometrial and endometriotic stromal cells expressed the Met receptor, which was activated by endogenous and exogenous HGF. HGF enhanced stromal cell proliferation and invasion. We also demonstrated that the HGF-stimulated stromal cell invasion was due in part to the induction of urokinase-type plasminogen activator, a member of the extracellular proteolysis system. In conclusion, the HGF/Met system is involved in the pathogenesis of endometriosis by promoting stromal cell proliferation and invasion of shed endometria and endometrial lesions via autocrine and paracrine pathways.

Abbreviations: Brdu, 5-Bromo-2'-deoxyuridine; ECM, extracellular matrix; FBS, fetal bovine serum; GAPDH, glycerol-3-phosphate dehydrogenase; HGF, hepatocyte growth factor; MMP, matrix metalloproteinase; MTT, 3-[4,5-dimethlthiazol-2-yl]-2,5-diphenyltetrazolium bromide; PA, plasminogen activator; PAI-1, plasminogen activator inhibitor-1; PF, peritoneal fluid; uPA, urokinase-type plasminogen activator.




This article has been cited by other articles:


Home page
Hum ReprodHome page
J. D. Wren, Y. Wu, and S.-W. Guo
A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium
Hum. Reprod., August 1, 2007; 22(8): 2093 - 2102.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
D. Gentilini, M. Busacca, S. Di Francesco, M. Vignali, P. Vigano, and A.M. Di Blasio
PI3K/Akt And ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17{beta}-estradiol and growth factors
Mol. Hum. Reprod., May 1, 2007; 13(5): 317 - 322.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S C J P Gielen, L C M Kuhne, P C Ewing, L J Blok, and C W Burger
Tamoxifen treatment for breast cancer enforces a distinct gene-expression profile on the human endometrium: an exploratory study
Endocr. Relat. Cancer, December 1, 2005; 12(4): 1037 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. N. Khan, H. Masuzaki, A. Fujishita, M. Kitajima, K. Hiraki, I. Sekine, T. Matsuyama, and T. Ishimaru
Interleukin-6- and tumour necrosis factor {alpha}-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis
Hum. Reprod., October 1, 2005; 20(10): 2715 - 2723.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society